Different effects of rosiglitazone and metformin on adipose tissue glucose uptake in type 2 diabetes

被引:0
|
作者
Yuan, MS
Melendez, PA
Iwamoto, M
Lee, JS
Shoelson, SE
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
585
引用
收藏
页码:A145 / A145
页数:1
相关论文
共 50 条
  • [21] Effects of chronic rosiglitazone therapy on gene expression in human adipose tissue in vivo in patients with type 2 diabetes
    Kolak, Maria
    Yki-Jarvinen, Hannele
    Kannisto, Katja
    Tiikkainen, Mirja
    Hamsten, Anders
    Eriksson, Per
    Fisher, Rachel M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (02): : 720 - 724
  • [22] Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review
    A. Natali
    E. Ferrannini
    Diabetologia, 2006, 49 : 434 - 441
  • [23] Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review
    Natali, A
    Ferrannini, E
    DIABETOLOGIA, 2006, 49 (03) : 434 - 441
  • [24] Effects of rosiglitazone in combination with metformin on cardiovascular biomarkers in type 2 diabetes subjects with microalbuminuria
    Bakris, GL
    McMorn, SO
    Weston, WM
    Huang, C
    Heise, MA
    CIRCULATION, 2005, 112 (17) : U917 - U917
  • [25] Rosiglitazone plus metformin to prevent type 2 diabetes mellitus
    Malaga, German
    Miranda, Juan J.
    LANCET, 2010, 376 (9750): : 1387 - 1387
  • [26] The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus
    Evren Fidan
    H. Onder Ersoz
    Mustafa Yilmaz
    Hulya Yilmaz
    Mustafa Kocak
    Caner Karahan
    Cihangir Erem
    Acta Diabetologica, 2011, 48 : 297 - 302
  • [27] The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus
    Fidan, Evren
    Ersoz, H. Onder
    Yilmaz, Mustafa
    Yilmaz, Hulya
    Kocak, Mustafa
    Karahan, Caner
    Erem, Cihangir
    ACTA DIABETOLOGICA, 2011, 48 (04) : 297 - 302
  • [28] Differential effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes
    Stocker, DJ
    Taylor, AJ
    Jezior, MR
    Langley, RW
    Vigersky, RA
    CIRCULATION, 2005, 112 (17) : U906 - U906
  • [29] The use of a combination of metformin and rosiglitazone in type 2 diabetes mellitus
    Demidova, T. Y.
    DIABETES MELLITUS, 2007, 10 (03): : 27 - 31
  • [30] Rosiglitazone plus metformin: combination therapy for type 2 diabetes
    Del Prato, S
    Volpe, L
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (06) : 1411 - 1422